Clinical Trials on Benign Prostate Hyperplasia in China

Total 467 results

Fuzhou General Hospital

Completed

Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates

Benign Prostate Hyperplasia

China
REMD Medical Technology
RenJi Hospital; Tongji Hospital; Qilu Hospital of Shandong University; Sun Yat-Sen... and other collaborators

Completed

Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

Comparison of TUSP Versus TURP for Treatment of Benign Prostatic Hyperplasia in a Small Prostate Volume

Benign Prostatic Hyperplasia

China
Southwest Hospital, China

Unknown

Transurethral Ventral Wall of Urethra-preserving Enucleation of Prostate

Benign Prostatic Hyperplasia

China
Fuzhou General Hospital

Completed

Plasmakinetic Enucleation of the Prostate to Treat Benign Prostatic Hypertrophy Patients With Large Prostate

BPH With Large Prostate

China
Zhujiang Hospital
The First Affiliated Hospital of Anhui Medical University; The First Affiliated... and other collaborators

Unknown

Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate (ERP)

Benign Prostatic Hyperplasia

China
Guang'anmen Hospital of China Academy of Chinese...

Completed

An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)

China
Boston Scientific Corporation

Completed

To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China

Benign Prostatic Hyperplasia (BPH)

China
Eli Lilly and Company

Completed

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)

Erectile Dysfunction | Benign Prostate Hyperplasia

China
Qianfoshan Hospital

Recruiting

A Diagnostic Study of Abnormal Acoustic Waves in Modern Pulse in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia | Radial Artery

China
GlaxoSmithKline

Completed

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia

China
Eli Lilly and Company

Completed

Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension

Benign Prostatic Hyperplasia

Japan
Changhai Hospital

Unknown

Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship

Prostatic Neoplasms | Benign Prostatic Hyperplasia | Digital Rectal Examination

China
Eli Lilly and Company

Completed

Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

Korea, Republic of, Japan
Boston Scientific Corporation

Completed

China Greenlight Registry Study (Post-market)

Benign Prostatic Hyperplasia (BPH)

China
Guang'anmen Hospital of China Academy of Chinese...

Recruiting

Effect of Electroacupuncture on Benign Prostatic Hyperplasia (EABPH)

Benign Prostatic Hyperplasia

China
Xintian Pharmaceutical

Recruiting

The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyperplasia (NQTIPS)

Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms

China
Olympus Surgical Technologies Europe

Terminated

Transurethral Vapor Enucleation Resection of the Prostate (TVERP), Bipolar TURis and HoLEP

Benign Prostatic Hypertrophy

China
GlaxoSmithKline

Completed

This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples

Prostatic Hyperplasia

China
Xiangfu Zhou

Unknown

The Influence of Benign Prostatic Hyperplasia on Bladder Function

Prostatic Hyperplasia

China
Hospital Authority, Hong Kong

Unknown

The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients

Prostatic Hyperplasia | Adrenergic Alpha-Antagonists

China
Shanghai East Hospital

Completed

The Predictive Value of Prostate Spherical Volume Ratio in Lower Urinary Tract Symptoms and Clinical Progression of Benign Prostatic Hyperplasia:A Single-center Paired Validating Confirmatory Study

Lower Urinary Tract Symptoms，Prostatic Hyperplasia

China
Astellas Pharma Inc
Astellas Pharma Singapore Pte. Ltd.

Completed

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

Overactive Bladder

Japan, Korea, Republic of
Hospital Authority, Hong Kong

Terminated

Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up

Prostatic Hyperplasia | Urinary Retention

China
GlaxoSmithKline

Completed

Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects

Prostatic Hyperplasia

Japan
Hospital Authority, Hong Kong

Terminated

Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up

Prostatic Hyperplasia | Acute Disease | Urinary Retention

China
Hospital Authority, Hong Kong

Completed

Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS

Prostatic Hyperplasia | Impotence

China
GlaxoSmithKline

Completed

Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Korea, Republic of, China, Japan, Taiwan
Hongqian Guo
AstraZeneca; Nanjing Chia-tai Tianqing Pharmaceutical

Recruiting

The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation

Prostate Cancer | Metastatic Prostate Cancer | Prostate Carcinoma

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
AstraZeneca

Recruiting

The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation (PROspect)

Prostate Cancer | Prostate Carcinoma | Metastatic Castration-resistant Prostate Cancer

China
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

Evaluation of the Metastasis and Recurrence of Prostate Cancer

Prostate Cancer Recurrent | Prostate Cancer Metastatic | Prostate Cancer (Diagnosis) | Prostate Cancer Stage

China
Tianjin Medical University Second Hospital

Recruiting

Selective Treatment According to Molecular Subtype of Prostate Cancer (STAMP)

Castration-resistant Prostate Cancer | Prostate Cancer Metastatic

China
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPC

Prostate Cancer Castration-resistant Prostate Cancer

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Completed

A Prospective Study Of Free-Hand Transperineal Image Fusion Targeted Biopsies Under Local Anesthesia

Prostate Neoplasm

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection

Prostate Neoplasm

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC

Prostate Cancer | Castration-resistant Prostate Cancer

China
Peking University

Withdrawn

PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer

Hormone Refractory Prostate Cancer

China
Tianjin Medical University Cancer Institute and...
Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaborators

Unknown

Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer (CRYO-PCA-III)

Stage III Prostate Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Molecular Phenotype Changes and Personalized Treatment for CRPC

Hormone Refractory Prostate Cancer

China
Xinhua Hospital, Shanghai Jiao Tong University...

Not yet recruiting

Multi-parametric Ultrasound Versus Multi-parametric MRI for Prostate Cancer Detection (TRUSVSMPMRI)

PROSTATE CANCER | Prostate Biopsy

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects

Castration-Resistant Prostate Cancer

China
Tianjin Medical University Cancer Institute and...
Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaborators

Unknown

Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer (CRYO-PCA-IV)

Stage IV Prostate Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC

Prostate Cancer Metastatic

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion

Prostate Cancer Patients

China
Shanghai Proton and Heavy Ion Center

Recruiting

Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer

Localized Prostate Cancer

China
Shanghai Proton and Heavy Ion Center

Unknown

Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer

Metastatic Prostate Carcinoma

China
Shanghai Humantech Biotechnology Co. Ltd
Shanghai Changhai Hospital,The First Affiliated Hospital of Naval Medical...

Recruiting

Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostate Cancer

China
Hinova Pharmaceuticals Inc.

Completed

A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch

Metastatic Castration Resistant Prostate Cancer

China
Sun Yat-sen University

Not yet recruiting

The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer

Metastatic Prostate Cancer

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer

Neoadjuvant Therapy | High Risk Prostate Cancer | Locally Advanced Prostate Cancer | Intense Endocrine Therapy

China

Clinical Trials on Benign Prostate Hyperplasia in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations